Jason Lettmann

ALXO

Jason Lettmann serves as director, officer: CHIEF EXECUTIVE OFFICER at ALX Oncology Holdings Inc. (ALXO). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

2 trades

$149.1K

Total Sells

7 trades

$13.64M

Net Position

Net Seller

$13.49M

Companies Traded

ALXO

Active Period

Dec 2021 – Mar 2026

9 total trades

Most Recent

Sell ALXO

Mar 23, 2026 · $26.7K

Jason Lettmann's Insider Trading at ALX Oncology Holdings Inc. (ALXO)

Buys

2 · $149.1K

Sells

7 · $13.64M

Total Shares Bought

96,633

Total Shares Sold

492,258

ALXO Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Mar 23, 2026	Sell	12,311	$2.17	$26.7K	293,609
Feb 17, 2026	Sell	2,201	$2.27	$5.0K	0
Sep 16, 2025	Buy	92,233	$1.08	$99.4K	0
Aug 15, 2025	Sell	2,382	$0.64	$1.5K	0
Feb 19, 2025	Sell	2,159	$1.15	$2.5K	0
Aug 14, 2024	Sell	2,191	$2.58	$5.7K	0
Mar 14, 2024	Buy	4,400	$11.31	$49.8K	0
Dec 13, 2021	Sell	325,377	$27.36	$8.90M	0
Dec 8, 2021	Sell	145,637	$32.26	$4.70M	0

Related Insiders

Shelly Pinto

SVP, FINANCE AND CAO

ALXOSell · Mar 23, 2026

GOODMAN COREY S

Director

ALXOBuy · Feb 2, 2026

Harish Shantharam

Chief Financial Officer

ALXOBuy · Aug 18, 2025

Explore More Insider Trading Data

ALXO Insider Trading Activity

View all insider trades at ALX Oncology Holdings Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity